Population
36 consecutive patients admitted with serum salicylate levels greater than 30 mg/dL
Design
Cohort
Authors
Loading...
May support risk stratification in salicylate toxicity; leaves open whether targeted monitoring improves outcomes.
Certain patients with elevated serum salicylate levels are at increased risk for developing pulmonary edema, which resolves with measures that lower salicylate levels.
John E. Heffner (1981) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: